Los Angeles, California (PRWEB) April 26, 2013
On April 26, 2013, the Food and Drug Administration issued an alert on its website to all health care practitioners that fraudulent version of the drug Botox, manufactured by Allergan, Inc. are being sold to medical practices in the U.S. (go to: goo.gl/iKRXI). Botox has FDA approval to treat migraine headaches, overactive bladders, hyperhidrosis (underarm sweating), and wrinkles.
"It really is an ongoing battle that the FDA is fighting against these counterfeiters,” says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. “It was only a few months ago that the FDA released a list of physicians that had purchased unapproved Botox from a Canadian pharmacy.”
According to the alert, a company operating under numerous aliases including “Onlinebotox” and “OnlineBotoxPharmacy” is placing vials labeled as foreign manufactured Botox into counterfeit outside cartons. Despite the internet-related names the company was not selling the counterfeit drug online but was sending mass faxes to solicit sales from medical offices.
Importantly, the FDA noted that only authentic Allergan-manufactured and FDA-approved Botox can be considered safe and effective for its approved uses. Even legitimately produced foreign Botox is not FDA approved for sale in the U.S.
“Given that the FDA issued a list of medical providers that purchased unapproved Botox, it is apparent that consumers cannot always rely on others to protect their safety,” says Dr. Ourian. “That’s why I created a six-point Botox checklist for anyone interested in getting a Botox treatment.”
Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvéderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about Botox can be found on Epione’s website.